Review article · 22 Jan 2024
EditorialPublished 25 Jun 2012
Inflammation and Pancreatic Cancer: A Tale of Two Cytokines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cancer is the most fatal of all gastrointestinal (GI) cancers, with only a 5.8% survival rate beyond five years after initial diagnosis. This cancer is characterized by a high mortality, rapid progression, and resistance to chemo and radiation therapy. Surgical resection is the only curative treatment for pancreatic cancer, but only less than 15% patients are eligible for surgery. The front-line treatment for metastatic pancreatic cancer has been adjuvant chemotherapy trials of gemcitabine and gemcitabine-based combinational therapy. However, over the past decade, no significant advances in efficacy of chemotherapeutic treatment have arisen, and the mean survival rate of those who have undergone such treatment has not improved.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cell Biology: Research & Therapy.
Opinion · 29 Dec 2023
Cellular Homeostasis and Disease: Current Insights and Therapeutic Implications
Perspective · 29 Dec 2023
Cellular Reproduction and Reprogramming: Implications for Therapeutic Advancements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCell Biology: Research & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Wei Li”
- BylineArticles whose byline prints “Andrew M. Albrecht”
- BylineArticles whose byline prints “Min Li”
